Search research articles
Contact Us
Filters
Showing results (471-480 of 512) with videos related to
Page
of 52
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
Annals of Neurology
|
December 25, 2024
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease
Ethan G Brown, Lana M Chahine, Andrew Siderowf, et al.
The Journal of Clinical Investigation
|
August 31, 2023
Effects of AFQ056 on language learning in fragile X syndrome
Elizabeth Berry-Kravis, Leonard Abbeduto, Randi Hagerman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
April 21, 2012
Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial
Carole L White, Jeff M Szychowski, Ana Roldan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 25, 2018
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Tanya Simuni, Andrew Siderowf, Shirley Lasch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits
Norbert Schuff, I-Wei Wu, Shannon Buckley, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 22, 2024
Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk
Ryan T Morse, Tyler J Nelson, Hannah C Liu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
Annals of Neurology
|
May 11, 2026
Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease
Andrew Siderowf, Laura E A Heathers, Kimberly Fabrizio, et al.
Page
of 52
Search research articles
Search
Showing results (471-480 of 512) with videos related to
Sort By:
Page
of 52
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
Annals of Neurology
|
December 25, 2024
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease
Ethan G Brown, Lana M Chahine, Andrew Siderowf, et al.
The Journal of Clinical Investigation
|
August 31, 2023
Effects of AFQ056 on language learning in fragile X syndrome
Elizabeth Berry-Kravis, Leonard Abbeduto, Randi Hagerman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
April 21, 2012
Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial
Carole L White, Jeff M Szychowski, Ana Roldan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 25, 2018
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Tanya Simuni, Andrew Siderowf, Shirley Lasch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits
Norbert Schuff, I-Wei Wu, Shannon Buckley, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 22, 2024
Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk
Ryan T Morse, Tyler J Nelson, Hannah C Liu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
Annals of Neurology
|
May 11, 2026
Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease
Andrew Siderowf, Laura E A Heathers, Kimberly Fabrizio, et al.
Page
of 52